Ad-RTS-hIL-12
ATI001-102 CPI Substudy 1.0
Phase 2 mab completed
Quick answer
Ad-RTS-hIL-12 for Glioblastoma is a Phase 2 program (mab) at Alaunos Therapeutics with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Alaunos Therapeutics
- Indication
- Glioblastoma
- Phase
- Phase 2
- Modality
- mab
- Status
- completed